OPOlga Andreevna Popova

Olga Andreevna Popova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olga Andreevna Popova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Arteriovenous malformations, aneurysms and cavernomas of the brain: their role in the development of vascular epilepsy (part 1)

    by А. V. Vasilenko, A. Yu. Ulitin, I. A. Lebedev, V. V. Goldobin, О. A. Popova, D. A. Novichkova, K. A. Kukin

    Vascular pathologies, despite the low percentage of prevalence among other etiological factors of epilepsy development, often cause such an important problem today as pharmacoresistance. This phenomenon can lead not only to a decrease in the quality of life of patients, but even to a fatal outcome.In this regard, the main task of this article will be to disclose the etiopathogenesis of epileptic seizures in patients with arteriovenous malformations, aneurysms and cavernomas. It is important to understand that the key role is played by the formation of organic pathology of the brain, the elimination of which should be paramount for the effective relief of epileptic seizures. Studying the issues discussed in this article can help structure the drug and surgical treatment of these patients, and perhaps even develop new algorithms.

  • Open Access

    Leptomeningeal melanomatosis: a case report

    by Diana Maratovna Fedorova, Alina Aleksandrovna Sokolova, Olga Andreevna Popova, Arina Eduardovna Yarkina, Anna Vital’evna Svintsova, Tatiana Viktorovna Kochetova, Kirill Pavlovich Raevskii, Ivan Vladimirovich Sheladev

    INTRODUCTION: Leptomeningeal melanomatosis is a rare neoplasm of the central nervous system that develops as a result of non-metastatic invasion by malignant melanocytic cells. The disease poses significant diagnostic challenges due to a wide range of clinical manifestations, lack of specific laboratory markers, and absence of definitive neuroimaging findings. Particular attention should be given to differentiating leptomeningeal melanomatosis from other central nervous system disorders, infectious and neoplastic diseases of different origin, and metastases, given the similarities in clinical presentation and pathomorphological features. CASE DESCRIPTION: A 20-year-old patient was diagnosed with leptomeningeal melanomatosis. Despite the absence of detectable melanoma in biopsy (surgical) specimens during antemortem pathological examination, the scientific data indicates that this does not preclude an aggressive clinical course following symptom onset. The report presents the patient’s clinical history and disease progression over one year, culminating in a fatal outcome. CONCLUSION: This case illustrates the diagnostic and therapeutic difficulties associated with rare central nervous system disorders, particularly when the diagnosis remains unclear over a long period. The scarcity of reliable data on leptomeningeal melanomatosis, the rapid disease progression, and its high mortality make timely diagnosis extremely challenging.